title: What is the best pharmacologic approach to managing moderate to severe heartburn?
authors.affiliation: Highlands Family Medicine, Lebanon, VA, USA. stmelton@cablenet-va.com
authors.forename: S T
authors.initials: ST
authors.lastname: Melton
authors.forename: A
authors.initials: A
authors.lastname: Cimmino
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000328:Adult; D004311:Double-Blind Method; D005260:Female; D006356:Heartburn / Q000145:classification / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D064747:Lansoprazole; D008297:Male; D015337:Multicenter Studies as Topic; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D054328:Proton Pump Inhibitors; D011899:Ranitidine / Q000627:therapeutic use*; D015203:Reproducibility of Results; D016896:Treatment Outcome
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D011899:Ranitidine; D009853:Omeprazole